Target intelligence / Profile preview

SLC2A13 pseudogene 1 (SLC2A13P1)

Target: SLC2A13P1
Molecular classification: pseudogene

Overview

SLC2A13 pseudogene 1 (SLC2A13P1) is a non-protein-coding genomic region that likely arose by duplication of the SLC2A13 gene, which encodes the proton myo-inositol cotransporter. Unlike SLC2A13, SLC2A13P1 does not produce a functional protein and is not involved in molecular transport or disease pathology. It is classified as a pseudogene and does not serve as a therapeutic target[5]. If the intent was to find information on the active, protein-coding "SLC2A13" (Solute Carrier Family 2 Member 13, HMIT), that is a transporter implicated in myo-inositol movement in neurons and various disease associations[1][3][4]; however, SLC2A13P1 specifically refers to its pseudogene form, which lacks therapeutic relevance.

Other names: SLC2A13P1SLC2A13 pseudogene 1

Beyond the preview

Go deeper on SLC2A13 pseudogene 1 (SLC2A13P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC2A13 pseudogene 1 (SLC2A13P1).

Explore the full profile